1. Tran TH, von Moltke LL, Venkatakrishnan K, Granda BW, Gibbs MA, Obach RS, Harmatz JS, Greenblatt DJ (2002) Microsomal protein concentration modifies the apparent inhibitory potency of CYP3A inhibitors. Drug Metab Dispos 30(12):1441–1445
2. Margolis JM, Obach RS (2003) Impact of nonspecific binding to microsomes and phospholipid on the inhibition of cytochrome P4502D6: implications for relating in vitro inhibition data to in vivo drug interactions. Drug Metab Dispos 31(5):606–611
3. Nagar S, Korzekwa K (2012) Commentary: nonspecific protein binding versus membrane partitioning: it is not just semantics. Drug Metab Dispos 40(9):1649–1652. https://doi.org/10.1124/dmd.112.046599
4. Rowland M, Tozer TN (2010) Membranes and distribution. In: Clinical pharmacokinetics and pharmacodynamics: concepts and applications. Wolters Kluwer Health/Lippincott William & Wilkins, Philadelphia, PA
5. Kanamitsu S, Ito K, Sugiyama Y (2000) Quantitative prediction of in vivo drug-drug interactions from in vitro data based on physiological pharmacokinetics: use of maximum unbound concentration of inhibitor at the inlet to the liver. Pharm Res 17(3)